Liverpool Health Economics

The LHE unit is led by Dr Alan Haycox, a Reader in Health Economics with extensive expertise in designing and conducting economic evaluation studies, dissemination at policy level, teaching at undergraduate and postgraduate, and links with a multitude of local, national, and international policy makers and academics.

 

Dr Alan Haycox

Reader in Health Economics and group Director

E: a.r.haycox@liverpool.ac.uk
T: +44 (0)151 795 3612

Alan is an internationally recognised Health Economist, expert advisor to NHS, pharmaceutical industry and a number of regulatory and funding authorities. In one of his previous roles, he was employed as Regional Health Economist in the North West Regional Health Authority, assisting in the prioritisation of healthcare provision to the population of the North West. He is a member of the NICE Technology Appraisals Committee and he is a founder of the Liverpool Technology Assessment Review (TAR) LHE. He specialises in pharmacoeconomic evaluation and has worked with an extensive range of pharmaceutical companies, guiding the economic evaluation of the new pharmaceutical products. His work is widely published and he is also a reviewer for a range of high profile journals.


Mr Mark Parker

Health Economic modeller

E: msparks@liv.ac.uk 

Mark is an experienced health economic modeller, who is nearing the end of his PhD studies. He is currently developing a modelling platform that will revolutionise the way economic evaluations are undertaken. Mark’s roles have mostly involved developing models and evidence based messages for a wide range of disease areas for global value dossiers and HTA submissions to NICE, SMC and CVZ, along with internal decision-making. He has experience in a vast range of disease areas and population modelling, with a strong educational background in economics, software development, distributed systems and computation, and Artificial Intelligence. This training, education and experience provide the means to apply the world's most advanced techniques to solve complex problems in a methodical, transparent and comprehensible way, with a core focus on knowledge transfer and developing evidence based value arguments for Health Technology Assessment.

 


Mr Antony P Martin

Health Economist

E: apmartin@liv.ac.uk

Antony is a health economist who has made significant contributions towards several innovative projects within LHE. He completed his BSc in Economics at the University of Liverpool and his MSc in Health Economics at City University London, funded by a scholarship from the NIHR. He has worked for a leading HEOR consultancy company, gaining experience in cost-effectiveness model adaptations, budget impact models, systematic literature reviews and health technology assessment reports. Antony has experience working within a range of therapeutic areas such as haematology, hepatitis C, HIV/AIDS, colorectal cancer, pre-term birth, and he has developed a keen interest in health policy debate. He has also developed an international profile after spending an extended periods of time studying and working in Brazil, Hong Kong and Peru.

 


Mr Paul Granby

Health Economist

E: p.granby@liv.ac.uk 

Paul has been working as a health economist after completing an MSc in Health Economics at the University of York, and has been a member of LHE since 2012. Paul works closely with Simon on several projects. He has also provided health-economic input into areas such as urology, cardiology, alcohol and reproductive services and hepatology. Likewise, Paul is involved in a number of NIHR and RfPb trials evaluating interventions to improve outcomes during gestation, labour and delivery; including the prevention of pre-term birth, management of preeclampsia and the cost-effectiveness of age-appropriate pharmaceutical formulations in newborns. Paul is also currently involved in evaluating the extent of hepatitis C infection in Europe, estimating the long-term survival, quality of life and resource impact of the disease, and working on strategies to improve access to treatment in high-risk groups.


Mr Simon Leigh

Health Economist

E: sleigh@liv.ac.uk

Simon has been working as a health economist aftercompleting an MSc in Health Economics at the University of York, and has been a member of LHE since 2012. He has provided health-economic input into areas such as urology, cardiology, alcohol and reproductive services and hepatology; however his main area of research concerns the economics of maternal, neonatal and perinatal health. Simon is involved in a number of NIHR and RfPb trials evaluating interventions to improve outcomes during gestation, labour and delivery; including the prevention of pre-term birth, management of preeclampsia and the cost-effectiveness of age-appropriate pharmaceutical formulations in newborns. Simon is also currently involved in evaluating the extent of hepatitis C infection in Europe, estimating the long-term survival, quality of life and resource impact of the disease, and working on strategies to improve access to treatment in high-risk groups.


Mr Brendan Collins

Public Health Advisor and Health Economist

E: brenc@liv.ac.uk

Brendan has been working as a health economist and modeller for over seven years. He has worked in the National Health Service, academia and for local authorities, with a focus on public health and health intelligence in the North West of England and in London. He specialises in assessing health inequalities and evaluating public health interventions. He has been involved in several service redesign projects around CVD, mental health and health visitors. He has experience of economic modelling using TreeAge and Excel VBA, as well as demand and capacity modelling using SIMUL8 Scenario Generator. He is currently completing his PhD on the topic of economic evaluation as applied to public health funded treatment of addiction. He teaches at undergraduate and masters levels at Liverpool and London South Bank University. He sits as an expert member on a NICE Public Health Advisory Committee.


Ms Fatemeh Behzadnejad

Trainee Health Economist

E: fatemeh.behzadnejad@mail.mcgill.ca

Fatemeh has an MSc in financial economics from the University of Montreal and is towards completing her PhD in economics at the Department of Economics, McGill University. The area of her PhD research has been well-being and environmental economics. The main focus of her research has been investigating the impact of environmental factors on individuals’ subjective well-being by deriving evidence from large cross-sectional and longitudinal surveys. This PhD project was funded by Quebec Research Fund in Society and Culture (FQRSC) for three years. Fatemeh has extensive experience in statistical analysis of health data sets as well as dynamic modelling. She joined the LHE team in February 2015. Currently, she is applying her experience in data analysis and decision modelling into a range of health economic problems. She is mainly involved in systematic literature review, data analysis and cost effectiveness analysis associated with a number of projects at LHE.